【文章內(nèi)容簡(jiǎn)介】
?Finished 9 DMPK package for filing ?Finished 740 Pharmacokiic studies, 30 toxicological studies and 40 cancer xenograft models in 2023 ? Owns the nonAAALAC and sFDA audited animal facility in Shanghai area ?12 rooms ?Owns the largest AAALAC accredited animal facility in Shanghai area ?with 46 animal rooms ? Can house ~300 monkeys and ~300 dogs ?Can house mice, rats, dogs, monkeys, hamster, rabbit and guineapig ?Owns the largest AAALAC accredited animal facility in Shanghai area Global CRO Revenue (Man Stanley, 2023) Global CRO revenue grows 13% annually to US $30 Billion in year 2023 From Man Stanley 2023 From Man Stanley 2023 Global CRO Preclinical Market From Man Stanley 2023 ?Based on Source: Frost Sullivan. 2023年全球 CRO總金額達(dá)到 163億美元,預(yù)計(jì) 2023年將達(dá)到 360億美元的規(guī)模 From Man Stanley 2023 From Man Stanley 2023 The Chinese CRO Market ?據(jù)美國普華永道最新出爐的 《亞洲地區(qū)醫(yī)藥研發(fā)外包發(fā)展動(dòng)態(tài)報(bào)告》顯示, 2023年中國醫(yī)藥研發(fā)外包( contractResearchOrganization簡(jiǎn)稱 CRO)市場(chǎng)已經(jīng)上升到約 ,較之 2023年 2500萬美元的市場(chǎng)足足增長了 10余倍,預(yù)計(jì)到 2023年可增長至 。不難看出,制藥工業(yè)正在加速減少傳統(tǒng)的內(nèi)部